History

2018Dec.“Cell Therapy for The Treatment of Neurodegeneration” granted in the US (Patent No.10,149,894)
 Nov.Patent “Sub-population of heterogenous bone marrow cells for the treatment of neurodegeneration” granted in Japan (Patent 6438527)
 Sep.Patent “Cell Therapy for The Treatment of Neurodegeneration” granted in the US (Patent No. 10,071,144)
Patent “Sub-population of heterogenous bone marrow cells for the treatment of neurodegeneration” granted in China(Patent ZL201380075366.9)
 Feb.Patent “Treatment of neurodegenerative diseases” granted in Taiwan (Patent I614341)
2017Dec.3rd party allocation of shares
 Sep.3rd party allocation of shares
 Jun.Patent “Sub-population of heterogenous bone marrow cells for the treatment of neurodegeneration” granted in Japan (Patent 6156889)
2015Mar.Patent “Cell production system” granted in Japan (Patent 5706610)
2013Jun.Patent “Sterilization equipment and method” granted in Japan (Patent 5294323)
 Apr.Capital reduction(Capital: 30M yen, Capital reserve: 31M yen)
2012Feb.3rd party allocation of shares
2011Dec.Patent “Transport support system and method for autologous cell for treatment” and other technology patent granted in Korea (Patent 10-1100658)
 Jul.Patent “Treatment of neurodegenerative diseases” granted in Japan (Patent 4621410: Product)
 Apr.3rd party allocation of shares
2010Nov.

Patent “Treatment of neurodegenerative diseases” granted in Japan (Patent 4621410: Process, Patent 4782237)

 Mar.

Patent “Treatment of neurodegenerative diseases” granted in Korea (Patent 10-0947576, 10-0947577)

2009May3rd party allocation of shares
 Jan.Non-clinical study started in the US
2008Sep.3rd party allocation of shares
 Aug.

3rd party allocation of shares

2007Nov.Dev. of NCS-01 started in the US
 Oct.3rd party allocation of shares
 Sep.Completed acquisition of RENOMEDIX INSTITUTE INC.
 Mar.3rd party allocation of shares
2006Apr.3rd party allocation of shares
2005Aug.Patent  “Transport support system and method for autologous cell for treatment” granted in Japan (Patent 3706128) (Granted to RENOMEDIX)
2004Dec.

NC Medical Research, Inc. established

Demonstration experiment of Medical Services  Network System was initiated  through METI Healthcare Services Support Project.

TOP
Copyright © 2017 NCMR. ALL Rights Reserved.